Azithromycin in the Management of Patients With Acute Exacerbation of Idiopathic Pulmonary Fibrosis

• Status: Not yet recruiting
• Trial end date: 2024-06-01

Summary

The study will assess the role of using azithromycin in managing acute exacerbation of Idiopathic pulmonary fibrosis

• Phase: N/A

Details

• Lead Sponsor: Assiut University
• Treatments: Azithromycin; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Prednisolone; Prednisolone acetate; Prednisolone hemisuccinate; Prednisolone phosphate